Offc Action Outgoing

SSS

SAGENT PHARMACEUTICALS, INC.

TRADEMARK APPLICATION NO. 77256745 - SSS - 07-753

To: Sagent Holding Co. (docketing@mbhb.com)
Subject: TRADEMARK APPLICATION NO. 77256745 - SSS - 07-753
Sent: 11/27/2007 11:55:26 AM
Sent As: ECOM116@USPTO.GOV
Attachments:

UNITED STATES PATENT AND TRADEMARK OFFICE

 

    SERIAL NO:           77/256745

 

    MARK: SSS           

 

 

        

*77256745*

    CORRESPONDENT ADDRESS:

          MARCIA IRELAND ROSENFELD      

          MCDONNELL BOEHNEN HULBERT & BERGOFF LLP    

          300 S WACKER DR STE 3200

          CHICAGO, IL 60606-6709         

           

 

RESPOND TO THIS ACTION:

http://www.gov.uspto.report/teas/eTEASpageD.htm

 

GENERAL TRADEMARK INFORMATION:

http://www.gov.uspto.report/main/trademarks.htm

 

 

    APPLICANT:           Sagent Holding Co.     

 

 

 

    CORRESPONDENT’S REFERENCE/DOCKET NO:  

          07-753        

    CORRESPONDENT E-MAIL ADDRESS: 

           docketing@mbhb.com

 

 

OFFICE ACTION

 

TO AVOID ABANDONMENT, THE OFFICE MUST RECEIVE A PROPER RESPONSE TO THIS OFFICE ACTION WITHIN 6 MONTHS OF THE ISSUE/MAILING DATE.

 

ISSUE/MAILING DATE: 11/27/2007

 

The assigned trademark examining attorney has reviewed the referenced application and has determined the following:

Identification of Goods

The wording in the identification of goods needs clarification because the nature of some goods is unclear.  Applicant must amend the identification of goods to specify the common commercial or generic name for the goods.  If there is no common commercial or generic name for the product, then applicant must describe the product and intended consumer as well as its main purpose and intended uses.  TMEP §1402.01.

 

Applicant may adopt the following identification of goods, if accurate: 

 

Class 5:       Pharmaceuticals, namely alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, vitamins, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, syringes sold filled with [indicate pharmaceutical contained in syringe], safety syringe devices namely, [indicate type of devices], and sensitizing agents for chemotherapy-resistant tumors; pharmaceuticals for treatment of cancer; pharmaceuticals to treat vascular diseases; drug delivery systems composed of [indicate, e.g., nanoparticles, polymer based injectable pharmaceuticals] sold as an integral component of drugs; injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases in the form of prefilled IV bags as a unit, sold separately or with devices for intravenous administration, namely transfer pins, vials, needles, and adaptors.

 

For assistance with identifying and classifying goods and/or services in trademark applications, please see the online searchable Manual of Acceptable Identifications of Goods and Services at http://tess2.gov.uspto.report/netahtml/tidm.html.

 

Please note that, while the identification of goods may be amended to clarify or limit the goods, adding to the goods or broadening the scope of the goods is not permitted.  37 C.F.R. §2.71(a); TMEP §1402.06.  Therefore, applicant may not amend the identification to include goods that are not within the scope of the goods set forth in the present identification.

 

 

/Michele-Lynn Swain/

Examining Attorney, LO 116

(PH) 571-272-9232

(FX) 571-273-9116

 

 

 

RESPOND TO THIS ACTION: If there are any questions about the Office action, please contact the assigned examining attorney. A response to this Office action should be filed using the form available at http://www.gov.uspto.report/teas/eTEASpageD.htm. If notification of this Office action was received via e-mail, no response using this form may be filed for 72 hours after receipt of the notification. Do not attempt to respond by e-mail as the USPTO does not accept e-mailed responses.

 

If responding by paper mail, please include the following information: the application serial number, the mark, the filing date and the name, title/position, telephone number and e-mail address of the person signing the response.  Please use the following address: Commissioner for Trademarks, P.O. Box 1451, Alexandria, VA 22313-1451.

 

STATUS CHECK: Check the status of the application at least once every six months from the initial filing date using the USPTO Trademark Applications and Registrations Retrieval (TARR) online system at http://tarr.uspto.gov.  When conducting an online status check, print and maintain a copy of the complete TARR screen.  If the status of your application has not changed for more than six months, please contact the assigned examining attorney.

 

 

 

 

TRADEMARK APPLICATION NO. 77256745 - SSS - 07-753

To: Sagent Holding Co. (docketing@mbhb.com)
Subject: TRADEMARK APPLICATION NO. 77256745 - SSS - 07-753
Sent: 11/27/2007 11:55:33 AM
Sent As: ECOM116@USPTO.GOV
Attachments:

                                                                

IMPORTANT NOTICE

USPTO OFFICE ACTION HAS ISSUED ON 11/27/2007 FOR

APPLICATION SERIAL NO. 77256745

 

Please follow the instructions below to continue the prosecution of your application:

  

VIEW OFFICE ACTION: Click on this link http://portal.gov.uspto.report/external/portal/tow?DDA=Y&serial_number=77256745&doc_type=OOA&mail_date=20071127 (or copy and paste this URL into the address field of your browser), or visit http://portal.gov.uspto.report/external/portal/tow and enter the application serial number to access the Office action.

 

PLEASE NOTE: The Office action may not be immediately available but will be viewable within 24 hours of this notification.

 

RESPONSE MAY BE REQUIRED: You should carefully review the Office action to determine (1) if a response is required; (2) how to respond; and (3) the applicable response time period. Your response deadline will be calculated from 11/27/2007.

 

Do NOT hit “Reply” to this e-mail notification, or otherwise attempt to e-mail your response, as the USPTO does NOT accept e-mailed responses.  Instead, the USPTO recommends that you respond online using the Trademark Electronic Application System response form at http://www.gov.uspto.report/teas/eTEASpageD.htm.

 

HELP: For technical assistance in accessing the Office action, please e-mail

TDR@uspto.gov.  Please contact the assigned examining attorney with questions about the Office action. 

 

        WARNING

1. The USPTO will NOT send a separate e-mail with the Office action attached.

 

2. Failure to file any required response by the applicable deadline will result in the ABANDONMENT of your application.

 

 

 


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed